Literature DB >> 8590595

A denaturant-insoluble form of tyrosine hydroxylase in PC12 pheochromocytoma cells.

R M Fleming-Jones1, P N McFadden.   

Abstract

A 6M urea-insoluble form of tyrosine hydroxylase (THi) was detected in PC12 pheochromocytoma cells by western blotting immunodetection methods, and the characteristics and mechanisms of formation of this insoluble species were investigated. THi accounts for about 4% of the immunodetectable tyrosine hydroxylase in exponentially dividing pheochromocytoma cells. It is unlikely that a subpopulation of dead or dying cells is the source of THi since essentially no changes in THi levels were detected when cell death was intentionally increased. To measure the kinetics of formation of cellular THi, exponentially dividing cells were metabolically labeled first with [3H]leucine and then with [14C]leucine, and though both 3H and 14C were incorporated into soluble tyrosine hydroxylase, the near absence of 14C in THi demonstrated that a lag period of at least a day exists between biosynthesis of tyrosine hydroxylase and the accumulation of measurable THi. The cellular accumulation of THi can evidently be regulated by the cell, since upon nerve growth factor (NGF) treatment of cells the total content of tyrosine hydroxylase increased and the content of THi decreased to yield, overall, a fivefold lower proportion of THi after 4 days. A large increase in urea-insoluble enzyme was found upon sublethal exposure of cells to ferrous ion and hydrogen peroxide, indicating that oxidative damage via metal-ion-catalyzed formation of hydroxide free radical can yield an enzyme that is similar in its insolubility to THi.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8590595     DOI: 10.1007/bf01886784

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  13 in total

1.  High-level expression of rat PC12 tyrosine hydroxylase cDNA in Escherichia coli: purification and characterization of the cloned enzyme.

Authors:  Y H Wang; B A Citron; P Ribeiro; S Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  The Lewy body in Parkinson's disease.

Authors:  L S Forno
Journal:  Adv Neurol       Date:  1987

Review 3.  Alzheimer's disease: a cell biological perspective.

Authors:  K S Kosik
Journal:  Science       Date:  1992-05-08       Impact factor: 47.728

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Solubilization and partial purification of tyrosine hydroxylase from bovine adrenal medulla.

Authors:  R Shiman; M Akino; S Kaufman
Journal:  J Biol Chem       Date:  1971-03-10       Impact factor: 5.157

Review 6.  Normal and abnormal biology of the beta-amyloid precursor protein.

Authors:  D J Selkoe
Journal:  Annu Rev Neurosci       Date:  1994       Impact factor: 12.449

7.  Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40.

Authors:  K K Andersson; C Vassort; B A Brennan; L Que; J Haavik; T Flatmark; F Gros; J Thibault
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

8.  Two types of spheroid bodies in the nigral neurons in Parkinson's disease.

Authors:  T Yamada; H Akiyama; P L McGeer
Journal:  Can J Neurol Sci       Date:  1991-08       Impact factor: 2.104

9.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Authors:  L A Greene; A S Tischler
Journal:  Proc Natl Acad Sci U S A       Date:  1976-07       Impact factor: 11.205

10.  Tyrosine hydroxylase in secretory granules from bovine adrenal medulla. Evidence for an integral membrane form.

Authors:  D M Kuhn; R Arthur; H Yoon; K Sankaran
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.